14P Biopsy-assessed vital residual tumor at the end of combined chemoradiation predicts poor PFS even in cases with delayed complete pathologic response

Résumé fourni par la source

Combined chemoradiation is the standard of care for patients with locally advanced cervical cancer (LACC). Magnetic resonance imaging (MRI), positron emission tomography-computed tomography (PET-CT), ultrasound, or biopsy are commonly used methods to assess therapy response. At our institution, punch biopsies are routinely performed at the last brachytherapy (BT) with re-biopsies six weeks later, in cases not showing complete response (pCR) at the end of radiotherapy. This study aimed to evaluate the prognostic value of histologically confirmed vital tumor residues after chemoradiation.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.